Aldo Scarpa
Impact in
- Cancer Research top 0.02%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 0.02%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
Papers in
- Oncology 286
- Pancreatic and Hepatic Oncology Research 177
- Lung Cancer Research Studies 45
- Co-authors
- Massimo Falconi (55 shared papers)Giuseppe Zamboni (76 shared papers)Paola Capelli (69 shared papers)Carlo M. Croce (11 shared papers)Claudio Luchini (105 shared papers)Stefano Volinia (3 shared papers)George A. Calin (3 shared papers)Chang‐Gong Liu (2 shared papers)
- Journals
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (39 papers)Oncotarget (14 papers)International Journal of Cancer (14 papers)Annals of Oncology (13 papers)Cancers (13 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Aldo Scarpa
592 papers receiving 32.7k citations
Aldo Scarpa's Hit Papers
Peers
Comparison fields: 5 of 179
- Cancer Research 8.1k
- Oncology 13.5k
- Epidemiology 8.2k
- Neurology 3.3k
- Pathology and Forensic Medicine 2.7k
Countries citing papers authored by Aldo Scarpa
This map shows the geographic impact of Aldo Scarpa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Scarpa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Scarpa more than expected).
Fields of papers citing papers by Aldo Scarpa
This network shows the impact of papers produced by Aldo Scarpa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Scarpa. The network helps show where Aldo Scarpa may publish in the future.
Co-authors
The 25 scholars most cited alongside Aldo Scarpa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 613 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A microRNA expression signature of human solid tumors defines cancer gene targets Hit paper breakdown → | 2006 | 4737 |
| 2 | TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Hit paper breakdown → | 2006 | 1160 |
| 3 | ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach Hit paper breakdown → | 2019 | 705 |
| 4 | TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system Hit paper breakdown → | 2007 | 700 |
| 5 | MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior Hit paper breakdown → | 2006 | 655 |
| 6 | Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2003 | 579 |
| 7 | 1999 | 462 | |
| 8 | Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway Hit paper breakdown → | 2009 | 420 |
| 9 | Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers Hit paper breakdown → | 2015 | 375 |
| 10 | 2010 | 340 | |
| 11 | 2007 | 313 | |
| 12 | 1994 | 307 | |
| 13 | 2009 | 301 | |
| 14 | 2007 | 291 | |
| 15 | Pancreatic adenocarcinomas frequently show p53 gene mutations. | 1993 | 279 |
| 16 | 2001 | 278 | |
| 17 | 2011 | 251 | |
| 18 | 2008 | 248 | |
| 19 | 2014 | 237 | |
| 20 | p53 gene mutation spectrum in hepatocellular carcinoma. | 1992 | 225 |
About Aldo Scarpa
Aldo Scarpa is a scholar working on Oncology, Molecular Biology, Epidemiology, Cancer Research and Surgery, having authored 613 papers that have together received 33.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (177 papers), Neuroendocrine Tumor Research Advances (116 papers), Cancer Genomics and Diagnostics (64 papers), Lung Cancer Research Studies (45 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (42 papers), Genetic factors in colorectal cancer (38 papers), Neuroblastoma Research and Treatments (35 papers) and Lymphoma Diagnosis and Treatment (31 papers). The work is most often cited by research in Cancer Research (8.1k citations), Oncology (13.5k citations), Epidemiology (8.2k citations), Neurology (3.3k citations) and Pathology and Forensic Medicine (2.7k citations). Aldo Scarpa has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Massimo Falconi, Giuseppe Zamboni, Paola Capelli, Carlo M. Croce, Claudio Luchini, Stefano Volinia, George A. Calin, Chang‐Gong Liu, Claudia Roldo and Manuela Ferracin. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Oncotarget, International Journal of Cancer, Annals of Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.